VistaGen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · IEX Real-Time Price · USD
3.650
-0.010 (-0.27%)
Jul 22, 2024, 10:06 AM EDT - Market open
VistaGen Therapeutics Employees
As of March 31, 2024, VistaGen Therapeutics had 40 total employees, including 39 full-time and 1 part-time employees. The number of employees increased by 6 or 17.65% compared to the previous year.
Employees
40
Change (1Y)
6
Growth (1Y)
17.65%
Revenue / Employee
$26,600
Profits / Employee
-$734,050
Market Cap
98.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
So-Young International | 1,357 |
Xtant Medical Holdings | 215 |
Adicet Bio | 143 |
Omega Therapeutics | 94 |
Sensus Healthcare | 35 |
Cardiff Oncology | 32 |
Checkpoint Therapeutics | 23 |
Eledon Pharmaceuticals | 20 |
VTGN News
- 13 days ago - Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine - Business Wire
- 25 days ago - Vistagen Awarded Mental Health America's Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year - Business Wire
- 5 weeks ago - Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update - Business Wire
- 6 weeks ago - Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024 - Business Wire
- 7 weeks ago - Vistagen to Present at the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference - Business Wire
- 2 months ago - Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference - Business Wire
- 3 months ago - Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue - Business Wire